Mice that received C5aR−/− BMDMs showed reduced tumor burden and improved survival compared to the mice that received WT BMDMs (Figure 2G), which phenocopied the results observed in C5aR−/− tumor-bearing mice. This evidence concerns the gene C5AR1 and neoplasm.